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Association of Maternal Self-Medication and
Over-the-Counter Analgesics for Children
WHAT’S KNOWN ON THIS SUBJECT: Self-medication with over-the-
counter (OTC) analgesics, particularly paracetamol (PCM), among
children is widespread and increasing. Parents often administer
the medicine. The health care system has little knowledge or
possibility to regulate OTC medication, and use of PCM for
children may be partly unjustiﬁed.
WHAT THIS STUDY ADDS: Maternal frequent self-medication with
OTC analgesics is associated with frequent use of OTC analgesics,
particularly PCM, among 6- to 11-year-old schoolchildren, even
when the child’s frequency of pain is accounted for.
abstract
OBJECTIVE: Self-medication with over-the-counter (OTC) analgesics, such
as paracetamol (PCM), among children and adolescents is increasing and
constitutes an important public health issue internationally. Reasons for
this development are unclear; parental inﬂuence is suggested. Our
objective was to examine whether self-medication with OTC analgesics
among school-aged children is inﬂuenced by maternal self-reported
health and medicine use, taking the child’s frequency of pain into account.
METHODS: A quantitative cross-sectional survey was conducted on 131
children aged 6 to 11 years and their mothers in the framework of the
Demonstration Of A Study To Coordinate And Perform Human Bio-
monitoring On A European Scale (DEMOCOPHES) European project. Partic-
ipants were selected from 1 urban and 1 rural area of Denmark, and
equally distributed in age and gender. Data were collected through struc-
tured interviews with all children and self-report questionnaires for
mothers regarding health, pain, and medicine use.
RESULTS: After adjusting for several sociodemographic and health
parameters, maternal use of OTC analgesics was signiﬁcantly associ-
ated with self-medication with OTC analgesics, particularly PCM, in our
population of schoolchildren, even when the child’s pain was adjusted
for (odds ratio 3.00, P = .008). A clear association between child pain
and OTC analgesic use was not found. Additionally, maternal health
(self-rated health, chronic pain, chronic disease, daily medicine
intake) did not signiﬁcantly inﬂuence child use of OTC analgesics.
CONCLUSIONS: Maternal self-medication with OTC analgesics is as-
sociated with self-medication of OTC analgesics, predominantly PCM,
among school-aged children, perhaps more than the child’s pain.
Maternal health seems of less importance. Information to parents
about pain self-management is important to promote appropriate PCM
use among schoolchildren. Pediatrics 2014;133:e291–e298
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Use of over-the-counter (OTC) analgesics
to treat pain among children is common
behavior internationally.1–3 This treat-
ment is often managed by parents with-
out consulting a physician.4 The act of
self-administrating OTC medicine, or
giving it to one’s child without medical
supervision, is termed self-medication.1
In many highly developed countries,
self-medication for children and ado-
lescents in case of pain and other minor
ailments has increased within the past
decades.5,6 The reasons for this de-
velopment are still unclear. A recent US
survey showed that in 1 week, twice as
many children aged 0 to 11 years re-
ceived OTC drugs as prescription medi-
cations.7
Paracetamol (PCM) is the most widely
used analgesic to treat mild pain in
children in the United States7 and in-
ternationally.8 Correspondingly, it is the
most frequently sold and used OTC
preparation for children.1,7,9 It is offered
in pharmacies and supermarkets world-
wide. Because individual purchase of OTC
preparations is not registered, the health
care system’s knowledge and regulation
of PCM use is limited.
PCM was introduced in the 1950s as
a mild analgesic and antipyretic. It is
considered safe for pediatric patients
when administrated in therapeutic dos-
age. Taking PCM frequently can lead
to medicine-induced headache.10 Over-
dosing can lead to liver damage and, in
worst case, liver failure.8 Intoxication
may happen after a single overdose ac-
cident, as well as after repeated doses
above recommendations.11 This is note-
worthy because parental dosing errors
with PCM are not uncommon.12 US data
showed more than 70 000 emergency
department visits in a 2-year period be-
cause of unintentional medicine over-
dose in 0- to 18-year-old children, PCM
accounting for 10% of those visits.13
Several factors might affect the use of
OTC analgesics for children and adoles-
cents. In European adolescents, female
gender and a self-reported poor self-
rated health (SRH) predict a more fre-
quent use of OTC medications, including
analgesics.14,15 Being bullied by peers
also seems to promote use of pain
medications in schoolchildren.16
Recently, parental inﬂuence on child self-
medication has gained attention. Several
studies have examined the inﬂuence of
parental socioeconomy. Some show an
associationwith high income and level of
education,1,4,17 whereas another found
an association with low socioeconomic
status.18 Parental attitudes toward OTC
medicinesmay affect the self-medication
for their child.19,20 Additionally parental
health and pain symptoms have been
suggested to be of importance.2 Mothers
could be of particular inﬂuence, because
they most often purchase and adminis-
ter OTC medications, including PCM.21
The current extensive self-medication
with OTC analgesics for children con-
stitutes an important public health issue
internationally.7 By increasing our un-
derstanding of what inﬂuences child
use of analgesics we can improve safety
and efﬁcacy of preparations such as
PCM. Further knowledge of parental
aspects that promote administration of
analgesics for children may contribute.
The purpose of this study was to ex-
amine the inﬂuence of maternal health
and medicine use on medication with
OTC analgesics, especially PCM, among
school-aged children.
METHODS
Setting
This study was carried out in school
settings of 2 locations: an urban and
a rural area in Denmark during the fall
of 2011. Recruitment and sampling was
closely connected with the Danish part
of Demonstration of a study to Coordi-
nate and Perform Human Biomonitoring
on a European Scale (DEMOCOPHES), a
European Union project demonstrating
the feasibility of a coordinated approach
onhumanbiomonitoringat theEuropean
level by examining levels of chemicals
(mercury, cadmium, phthalates, and
cotinine) in comparable populations of
schoolchildren and their mothers in 17
European countries.22,23
Design/Population
The design was a quantitative cross-
sectional survey by using structured
interviews with children and corre-
sponding self-report questionnaires for
mothers.
In DEMOCOPHES, 144 Danish children
aged 6 to 11 years and their mothers
were included. The participants were
recruited from4schools ineacharea. All
parents of ﬁrst to sixth grade pupils
received written information about
DEMOCOPHES and this study via the
schools’ E-mail systems. Furthermore,
information was posted in local news-
papers. Participants were invited to
self-assign on a project Web site.
The childrenwere equally distributed in
age, gender, and urban/rural location.
Only children who had lived in the area
for5yearsandstayedwiththeirmothers
a minimum of 16 days per month were
included. Children or mothers with di-
abetes, liver or kidney disease, or
who did not understand Danish were
excluded.
At the day of participation, all DEMO-
COPHES participants were invited to
also take part in this study; 131 pairs of
mother and child agreed. Reasons for
not participating were lack of time (9
pairs), discomfort after blood sampling
(2 pairs), and unwillingness of the child
(2 pairs).
Data Collection
Collection of data took place in the school
nurses’ facilities of 3 schools. All partic-
ipants had speciﬁc appointments; 1 hour
was scheduled for each pair. They de-
livered questionnaires, and urine, hair,
and blood samples, and subsequently
the mother ﬁlled out the questionnaire
for the current study while the child was
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interviewed by the ﬁrst author (J.F.J.) in a
separate room. J.F.J. is trained in struc-
tured interviewing20 and has 3 years’
experience as a physician in hospitals
and general practice. If a mother had
problems answering the questionnaire,
she could ask J.F.J. for advice.
Thestructured interviewguidecontained
21 items regarding health and health-
related quality of life (HRQoL), experi-
ences with pain, and medicine use of
the child. The questionnaire for mothers
contained39 items:25concerninghealth,
pain,andmedicineuseof thechild,and14
concerning health of the mother. Com-
pleting the questionnaire and interview
took 10 to 15 minutes.
HRQoL of the children wasmeasured by
the validated Pediatrics Quality of Life
inventory.24 Items regarding child pain
were developed from the Lübeck Pain
Screening Questionnaire.25,26 Items on
medicine use were designed speciﬁ-
cally for this survey. Maternal SRH was
assessed by 1 item from the Danish
Short Form-36 inventory.27 The ﬁnal
questionnaires were pilot tested with 5
mother-child pairs before use. Only mi-
nor corrections were made.
Measurements
Two items in the self-report question-
naire covered the use of OTC analgesics
for children: if the child had receivedOTC
analgesics in the past 3 months (replies
weredichotomized intoyesversusno/do
notknow), andhowoften in thepastyear
the child was given PCM (replies were
dichotomized into every second month
ormoreoften versusnotatall/onlya few
times). These items constitute the 2 key
outcomes for this study (Fig 1).
To clarify child recurrent pain, both the
child and mother reported if the child
oftenexperiencedpainanddescribedthe
frequency (Fig 1). Pain occurring a mini-
mum of weekly in a period of 3 months
was described as recurrent pain in ac-
cordance with previous studies.25 Ma-
ternal health was described by 5 items
for the mother concerning SRH, pain,
chronic disease, and medicine use
(Fig 1). Maternal SRH was dichotomized
into excellent/very good versus good/
fair/poor. Maternal use of analgesics
was dichotomized into less than once
a month versus monthly or more often.
Statistics
Data were analyzed with SPSS for
Windows statistical software, version 20
(IBM SPSS Statistics, IBM Corporation,
Chicago, IL). P values , .05 were con-
sidered signiﬁcant.
Sociodemographic variations in medi-
cine use were assessed by x2 tests.
Associations between maternal health
and the key outcomes were assessed
by univariate and multivariate logistic
regression analyses. Because the in-
cluded maternal health factors might
be correlated and hide each other’s
effects in a full multivariate model, we
did a backwardmodel reduction (BMR)
for each health factor; iteratively, the
health factor with the lowest P value
was removed until only the examined
health factor and factors with P , .05
were left in the model.
Ethics
TheDEMOCOPHESstudywasapprovedby
the regional ethics committee (approval
no H-3–2011–075). Participation was
FIGURE 1
Key items of the structured interview guide/questionnaire.
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voluntary and it was at any time possi-
ble to withdraw from the study, or part
of it. All participants received a cinema
ticket for their contribution. Children
were not asked questions interpreted
as worrying or burdening to them. The
current study and DEMOCOPHES were
reported to the Danish Data Protection
Agency. All data are anonymous and
stored according to Danish law re-
garding data storage.
RESULTS
Table 1 shows the population charac-
teristics and the proportion of children
who used OTC analgesics. In total, 59
children (45%) had been given OTC
analgesics in the last 3months. Of these,
49 children received PCM, 2 were given
ibuprofen, and 8 mothers did not reg-
ister the name of the given analgesic. Of
the 131 children, 29 (22%) had received
PCM at least every second month in the
past year. Only 2 children reported to
self-administer OTC analgesics.
There was no signiﬁcant difference in
childage,gender,orHRQoL foranyof the
2 child self-medication outcomes. Nei-
ther was maternal age, education, or
the family’s place of residence or in-
come associated with use of OTC anal-
gesics for the child (Table 1).
The41childrenreportingrecurrentpains
showeda tendency to self-medicatewith
OTC analgesics more frequently; how-
ever, this association was insigniﬁcant.
Maternal report of child recurrent pain
was associated with self-medication of
the child with PCM at least every second
month in the past year (Table 1).
A third of the mothers reported chronic
pains (headache or musculoskeletal
pains); a similar proportion reported
chronic disease (hypertension, asthma,
or allergy). One in 4 mothers took med-
icine daily (asthma or allergy medi-
cations, antihypertensives, analgesics,
or antidepressants). Fifty-one mothers
(39%)usedOTCanalgesicsatleastmonthly.
Maternal monthly self-medication with
OTC analgesics was signiﬁcantly associ-
ated with a more frequent use of analge-
sics for her child in both child self-
medication outcomes (Table 1).
Maternal Health and Child Use of
OTC Analgesics
The univariate analysis in Table 2 shows
that maternal monthly self-medication
with OTC analgesics was signiﬁcantly
associated with a more frequent use of
OTC analgesics for her child in the past
3 months and the previous year (odds
ratio [OR] 2.82 and OR 2.79, P , .05).
This association remained signiﬁcant
when adjusting for background factors
(child age, gender, and number; ma-
ternal age and education level; place of
residence; and household income), the
othermaternal health parameters, and
child recurrent pains (OR 3.07 and OR
4.71, P , .05).
After BMR, the association between ma-
ternal monthly self-medication with
analgesicsandchildself-medicationwith
analgesics within the past 3 months
remained signiﬁcant (OR 3.00, P , .05).
However, BMR resulted in the associ-
ation between maternal monthly use
of OTC analgesics and frequent self-
medication with PCM in the past year
becoming insigniﬁcant (OR 2.54, P =
.069). No other maternal health
parameters showed association with
child self-medication with OTC anal-
gesics.
Child Recurrent Pain and Use of
OTC Analgesics
Table 2 shows that child report of re-
current pain was signiﬁcantly asso-
ciated with the child’s use of OTC
analgesics in the past 3 months when
adjusting for background and health
factors, whereas maternal report of
child recurrent pain was not. However,
the mother’s report of child recurrent
pain predicted child self-medication
with PCM at least every second month
in the past year by an OR of 7.02, P, .05,
after BMR.
DISCUSSION
Main Findings
This study demonstrates a clear asso-
ciation between self-medication with
OTC analgesics in schoolchildren and
their mothers. It appears that maternal
medicating behavior regarding OTC
analgesics inﬂuenceswhetherherchild
receives an OTC analgesic, particularly
PCM, evenwhen the child’s pain is taken
into consideration.
Our study did not ﬁnd any association
between maternal SRH, chronic pain,
chronic disease, or daily medicine in-
take and the self-medication with OTC
analgesics for her 6- to 11-year-old
child. We found a weak association
between reports of child recurrent pain
and the child receiving OTC analgesics
more often; however, this was not
consistently signiﬁcant.
Relation to Previous Studies
The number of published works about
child self-medication is small, so this
makes the basis for comparison lim-
ited. However, our results are in ac-
cordance with previous studies showing
an association between maternal and
child self-medication with OTC medi-
cations.17,20,28 We did not detect any in-
ﬂuence of socioeconomic factors, as
suggested by earlier studies, perhaps
due to our limited study population. In
2003, Tobi et al15 found a high parental
education level to be associated with
increased child OTC drug use. Corre-
spondingly, Du and Knopf1 showed more
frequent child self-medication in families
with well-educated mothers and high
family income in Germany, whereas
Holstein et al18 found higher rates of
medication for aches among children
from lower socioeconomic groups. Two
studies found no inﬂuence of parental
socioeconomic status.4,17
Ourﬁndingsconcurwithrecent research
indicating that parents’ own health
and medicating behavior inﬂuence
the self-medication of their children.
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Parents have shown to be the most
important source of OTC medications
for 11- to 13-year-old schoolchildren.29
In 2012, Andersen et al2 found that
children aged 2 to 17 years whose
parents suffer from headaches re-
ceive more medicine for headaches,
even when the child’s symptom is
adjusted for. Parental attitudes and ex-
perience with medication seem to affect
their willingness to administer medicine
to their children,19,20 and possibly for the
TABLE 1 Characteristics of the Study Population and Children’s Use of OTC Analgesics and PCM (n = 131)
Total Child Given OTC
Analgesics
in Past 3 mo
Pearson x2, P Child Given PCM
Every Second Month
in Past Year
Pearson x2, P
n (Valid Percent) n (Valid Percent)
Children
Total 131 59 (45) 29 (22)
Girls 69 35 (51) .17 17 (25) .47
Boys 62 24 (39) 12 (19)
Age 6–7 y 41 19 (46) .81 9 (22) .99
Age 8–9 y 46 19 (41) 10 (22)
Age 10–11 y 44 21 (48) 10 (23)
First born 62 30 (48) .71 12 (19) .72
Second born 47 19 (40) 11 (23)
Third+ born 22 10 (46) 6 (27)
Recurrent pains, child report 41 23 (56) .09 13 (32) .08
No recurrent pains, child report 90 36 (40) 16 (18)
Recurrent pains, mother report 40 22 (55) .13 16 (40) .001
No recurrent pains, mother report 91 37 (41) 13 (14)
Child with chronic disease 25 11 (44) .88 10 (40) .02
No chronic disease 103 47 (46) 19 (18)
Missing 3
Lowest quartile physical HRQoLa 36 17 (47) .76 10 (28) .34
Highest 3 quartiles physical HRQoL 95 42 (44) 19 (20)
Lowest quartile psychosocial HRQoL 35 18 (51) .38 9 (26) .55
Highest 3 quartiles psychosocial HRQoL 96 41 (43) 20 (21)
Mothers
Age 31–37 y 27 9 (33) .58 3 (11) .33
Age 38–40 y 34 17 (50) 8 (24)
Age 41–43 y 34 16 (47) 7 (21)
Age 44–52 y 36 17 (47) 11 (31)
Primary/secondary school 15 7 (47) .64 3 (20) .84
Short-cycle higher education/Bachelor 75 36 (48) 18 (24)
Master, PhD, etc. 41 16 (39) 8 (20)
SRH poor/fair/goodb 35 16 (46) .93 9 (26) .55
SRH very good/excellent 96 43 (45) 20 (21)
Chronic pains, current or previous 43 21 (49) .62 12 (28) .30
No chronic pains 86 38 (44) 17 (20)
Missing 2
Monthly use of analgesics 51 31 (61) .005 17 (33) .02
No monthly use of analgesics 79 28 (35) 12 (15)
Missing 1
Chronic disease 43 18 (42) .57 11 (26) .53
No chronic disease 87 41 (48) 18 (21)
Missing 1
Daily medicine intake 31 13 (42) .66 8 (26) .54
No daily medicine intake 97 45 (46) 20 (21)
Missing 3
Family/Household
Rural 65 30 (46) .80 15 (23) .87
Urban 66 29 (44) 14 (22)
Low income, ,78 000 $/year 43 19 (44) .91 11 (26) .36
Middle income, 78 000–105 000 $/y 33 14 (42) 9 (27)
High income, .105 000 $/y 51 24 (47) 8 (16)
Missing 4
a HRQoL of the children was assessed from the child report of the Pediatric Quality of Life inventory.
b SRH of the mothers was assessed by a validated item from the Short Form-36 inventory.
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children to self-administrate OTC prod-
ucts in adolescence. A qualitative survey
by Hatchette et al30 concluded that ma-
ternal advice and medicating behavior
affects the pain self-management in
adolescents.
Interestingly, we did not ﬁnd a correla-
tion between child recurrent pains and
use of OTC analgesics, as other studies
have found.14 This alsomay be explained
by a relatively small study population.
However, a survey has shown that al-
though medication with analgesics
among adolescents has increased in the
past decades, the prevalence of self-
reported pain is unchanged.31 Thus,
other factors may account for the in-
creasing self-medication among chil-
dren and adolescents.
Limitations
The 2-question outcome of this study is
simplistic; however, this design was
chosen to maximize compliance and
dedication of the participants, and
receive the most accurate information
with a small population. Previous OTC
medication studies have applied
1-question outcomes.6,17
Our limited sample size may result in
associations between maternal health
and child self-medication to remain
undetected. Our population also meant
wecouldnot investigate the inﬂuenceof
paternal health. However, Danish re-
search shows that in 90% of families,
themother is themain administrator of
medicine to the children.20 Corre-
spondingly, most OCT medicine ads are
targeted for women. Maternal in-
ﬂuence might be of more importance
than paternal.
The retrospective design means that our
resultsmightbe inﬂuencedbyrecallbias.
Previousmedicationstudieshaveapplied
shortreportperiodsof2daysor1week.1,17
Our report period of 3 months and 1 year
could lead to imprecise replies. However,
this period was chosen to identify a long-
term use of analgesics rather than the
speciﬁc use during a few randomly se-
lected days.
The validity of self-reportedmedicine use
is unknown. One study demonstrates a
high agreement between adolescents’
andmothers’ reports of childmedication
for aches.32 Further validation of PCM
intake by measurements of urine con-
centrations was not performed, as it re-
ﬂects PCM intake only of the previous day.
Implications/Perspectives
Because parents are responsible for
the self-medication of their children, it
is important to understand what leads
to the parent giving a drug ornot, and to
target parents risking inappropriate
use of OTC analgesics. This article
contributes to this understanding. It
seems that mothers who react to pain
by self-medicating with analgesics tend
to treat their child the sameway. Taking
analgesics can be seen as a coping
strategy to lessen the discomfort of
pain.33 Children adopt the coping
TABLE 2 ORs and P Values for Associations Between Child Recurrent Pain, Maternal Health Factors, and Children’s Use of OCT Analgesics
Univariate Multivariate
(Background)a
Multivariate
(Background+Health)b
Final Modelc
OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value OR (95% CI) P Value
Outcome 1: The child has been
treated with analgesics within
previous 3 mo (ANG-3 mo).
Child recurrent pain, child report 1.92 (0.91–4.05) .09 2.68 (1.11–6.50) .03 1.71 (0.60–4.84) .31 2.21 (0.88–5.53) .09
Child recurrent pain, mother report 1.78 (0.84–3.78) .13 2.13 (0.91–5.02) .08 1.65 (0.59–4.61) .34 2.11 (0.86–5.17) .10
Mother SRH poor/satisfactoryd 1.04 (0.48–2.26) .93 0.86 (0.37–1.99) .73 1.02 (0.37–2.80) .97 0.94 (0.39–2.62) .89
Mother chronic pains 1.21 (0.58–2.51) .62 1.36 (0.59–3.12) .48 0.99 (0.34–2.88) .99 0.89 (0.36–2.21) .80
Mother monthly use of analgesics 2.82 (1.37–5.84) .005 3.24 (1.46–7.19) .004 3.07 (1.26–7.47) .01 3.00 (1.33–6.73) .008
Mother chronic disease 0.81 (0.39–1.69) .57 0.75 (0.34–1.65) .47 0.64 (0.23–1.80) .40 0.67 (0.29–1.55) .35
Mother daily medicine intake 0.84 (0.37–1.89) .67 0.81 (0.33–2.01) .66 0.77 (0.25–2.41) .66 0.64 (0.25–1.67) .36
Outcome 2: The child has been
treated with PCM at least every
second month in the past year (PCM-year).
Child recurrent pain, child report 2.15 (0.92–5.03) .08 2.04 (0.73–5.68) .17 0.65 (0.18–2.35) .51 1.00 (0.31–3.21) .99
Child recurrent pain, mother report 4.00 (1.69–9.48) .002 7.12 (2.22–22.84) .001 11.44 (2.53–51.82) .002 7.02 (2.14–23.07) .001
Mother SRH poor/satisfactoryd 1.32 (0.53–3.25) .55 1.18 (0.43–3.25) .74 1.64 (0.45–5.99) .46 0.83 (0.28–2.48) .74
Mother chronic pains 1.57 (0.67–3.68) .30 1.21 (0.46–3.17) .70 0.28 (0.06–1.32) .11 0.31 (0.08–1.19) .09
Mother monthly use of analgesics 2.79 (1.20–6.51) .02 2.66 (1.05–6.73) .04 4.71 (1.33–16.62) .02 2.54 (0.93–6.92) .07
Mother chronic disease 1.32 (0.56–3.11) .53 1.08 (0.42–2.78) .88 0.98 (0.25–3.8) .98 0.69 (0.23–2.02) .49
Mother daily medicine intake 1.34 (0.52–3.44) .54 1.02 (0.34–3.01) .98 0.89 (0.21–3.77) .88 1.00 (0.32–3.15) .99
CI, conﬁdence interval.
a Multivariate analysis adjusted for 7 background factors: child gender, child age, First/Second/Third+ born child, maternal age, maternal education level, place of residence, and household
income.
b Multivariate analysis adjusted for the 7 background factors and the other health factors (child pain, mother SRH, mother chronic pains, mother use of analgesics, mother chronic disease).
c Final model: After BMR of health factors, when only the examined health factor and health factors signiﬁcantly associated with the outcome are left in the model.
d SRH of the mothers was assessed by a validated item from the Short Form-36 inventory.
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strategies of their parents, and self-
medication behavior may be passed on
within families. This socialization path-
way explaining the association between
parental health and child self-medication
has previously been described.2,34 Our
results suggest that maternal illness,
pain, or prescription medicine intake
plays a smaller role in PCM use for
children. Perhaps a mother’s view of
PCM affects the use for her child more
than her own health does.
Because PCM is available OTC, the pur-
chase is mainly controlled by package
sizeandprice,besideshealth information
campaigns. However, it is important to
facilitate the appropriate parental use of
PCM for children to improve safety and
efﬁcacy of the drug. Parents should be
informed about indications as well as
risks, storage, and dosing.
When should a child receive PCM? Opin-
ions are varied also among health care
personnel.35 PCM is considered a safe
and effective treatment of fever andmild
childhood pain, and has few risks asso-
ciatedwith intermittent use. It should not
be used to treat colds, coughs, sleep
problems, or mood swings in children,
as previous studies disclose.34 Some-
times a child’s recurrent pain is a sign
of psychological issues that need atten-
tion. Functional pain is a well-known
phenomenon in children, where analge-
sics are of little beneﬁt.36 In other cases,
analgesics may mask serious symptoms
and thereby postpone treatment of an
underlying disease. Persistent pain of
unknown reason in a child should al-
ways be examined by a physician.35
Excessive PCM use involves risks of
medicine-induced headache and hepa-
totoxicity. New research implies that
PCM may affect the decreasing re-
productive abilities of Danish men.37
Additionally, PCM is the most frequently
used drug in teenage suicide attempts,
perhaps because it is well-known and
accessible at home.29 Therefore, it is
relevant to look into the attitude of “Try
giving PCM and see if it helps” that
seems to exist in the population and
perhaps among health care employees.
Debating use of OTC analgesics in
the medical community and improv-
ing communication with parents about
childhood pain management may affect
andensurethesafetyofchildPCMuse.7,35
In this regard, health education pro-
grams, such as the US PROTECT initiative,
to keep children safe from accidental
overdoses are valuable.
CONCLUSIONS
Maternal self-medication with OTC
analgesics inﬂuences the use of OTC
analgesics, predominantly PCM, for
her child, even when the child’s fre-
quency of pain is taken into account.
Other maternal health parameters,
such as maternal SRH, chronic pain,
chronic disease, or daily medicine
intake were of less importance to
self-medication with PCM in our
population of 6- to 11-year-old chil-
dren.
To further investigate the self-medication
with OTC analgesics for children, pro-
spective studies documenting child pain
and analgesic use are needed. In-
tervention studies implementing paren-
tal education might clarify how pain
management campaigns targeted for
parents affects child analgesic use. An
investigation of OTC analgesic use among
physicians,nurses,andpharmacistsmay
show varying administration across
countries or sections of the health care
system. Finally, measuring PCM levels
in blood or urine will give objective
information about the extent of PCM
exposure.
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